docdok.health increases safety of coronavirus vaccinations
The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The company has agreed a partnership with the German umbrella organization of specialized physicians (SpiFa).
As detailed in a press release, the Basel start-up docdok.health AG is the new innovation and technology partner of SpiFa (Spitzenverband Fachärzte Deutschland), the German umbrella organization of specialized physicians. SpiFa has recommended to its members – some 160,000 doctors – that they should use an app developed by docdok.health after COVID-19 vaccinations.
The app can be used to collect data which is then anonymously forwarded on to the Paul Ehrlich Institute, otherwise known as the Federal Institute for Vaccines and Biomedicines in Germany. A broad database should also allow processes to be optimized, which will result in improved safety and efficacy for COVID-19 vaccinations.
“We see huge potential for our app in Switzerland”, comments Yves Nordmann, co-founder and Chief Medical Officer (CMO) of docdok.health, in the press release. Founded in 2017, docdok.health AG develops solutions to improve communications between doctor and patient. “The focus is on healthcare provision that prioritizes quality over quantity with the help of digital therapy solutions”, explains co-founder and CEO Ulrich Mühlner, who was also formerly a Senior Manager at Novartis.
Share this article
You may also be interested in
The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...Read More
RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...Read More